查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1874005

细胞治疗仪器市场

Cell Therapy Instrument Market
出版日期: | 出版商: The Insight Partners | 英文 150 Pages | 商品交期: 1-5个工作天内

价格
简介目录

2024年细胞治疗仪器市场价值约232.8亿美元，预计2031年将成长至约599.8亿美元。预计该市场从2031年到2032年将经历15.4%的年复合成长率（CAGR），细胞治疗仪器的自动化製造将呈现显着趋势。

细胞治疗仪器市场分析

细胞疗法是指将活细胞注射、植入或移植到患者体内。例如，在免疫疗法中，癌症患者可能会接受T细胞注射。细胞疗法的给药方式多种多样，从简单的注射到使用专用设备的复杂外科植入物不等。细胞疗法适用于多种疾病，其中癌症是影响神经系统最严重的疾病之一。其他应用包括心臟疾病（如心肌梗塞和心臟衰竭）、糖尿病、肌肉骨骼疾病、遗传性疾病以及皮肤和软组织创伤。

细胞治疗仪器市场概览

嵌合抗原受体（CAR）T细胞疗法是最有前景的癌症治疗方法之一，每年都有大量的临床前和临床试验开展，以拓展其应用范围。经过多年的研究，CAR-T细胞疗法可望进一步发展。未来的研究不仅将探索自体和异体CAR-T细胞产品，还将探索新型体内CAR-T细胞基因疗法及其在血液系统恶性肿瘤以外疾病的疗效。

战略洞察

细胞治疗仪器市场的驱动因素与机会

细胞治疗製造技术的进步

细胞疗法研究的不断发展，推动了细胞治疗仪器的显着进步，这些仪器旨在治疗遗传性疾病和增强免疫反应。多家公司提供试剂盒和酵素等必需耗材，而其他公司则提供各种细胞治疗流程所需的仪器、设备和软体。

使用专用设备对于生产T细胞、造血干细胞（HSC）、间质干细胞（MSC）、多能干细胞（PSC）和神经干细胞（NSC）等细胞疗法至关重要。由于这些产品来自人类或动物细胞，因此保持无污染环境至关重要。因此，细胞疗法中使用的仪器旨在防止污染并提高产量。康宁公司、日立化成先进治疗解决方案有限公司、Cytiva（通用电气公司旗下）、赛默飞世尔科技公司、Invetech和Miltenyi Biotec等知名公司已开发出用于细胞疗法的各种仪器和耗材。

亚太和中东地区的生物技术产业正迅速扩张，这主要得益于私营和公共部门的大量投资和战略倡议，尤其与北美和欧洲相比更是如此。例如，2024年12月，日本安斯泰来製药公司宣布以30亿美元收购基因治疗公司Audentes Therapeutics。同样，2024年11月，富士软片公司宣布计划在其合约开发和生产业务中投资约1.2亿美元（130亿日元）用于基因治疗。此外，日本药品和医疗器材管理局（PMDA）已批准两款基因治疗产品获得「先驱」（Sakigake）认定，该认定类似于美国FDA的「突破性疗法」认定和EMA的「优先药物」（PRIME）认定，预计每年至少批准一种疗法。亚洲各国本土企业的此类策略倡议预计将在不久的将来推动对细胞治疗仪器的需求。

细胞治疗仪器市场細項分析

细胞治疗仪器市场的分析按疾病和服务提供者进行细分。

  • 市场按产品分为耗材、设备、系统和软体，其中耗材部分在 2023 年占据最大的市场份额。
  • 按细胞类型划分，市场分为人类细胞和动物细胞，其中热塑性塑胶在 2023 年占据最大的市场份额。
  • 按製程划分，市场分为细胞处理、製程监控和品质控制、细胞保存、分销和处理，其中细胞处理部分在 2023 年占据市场份额领先地位。
  • 以最终用户划分，市场分为研究机构、生命科学研究公司和其他最终用户，其中生命科学研究公司在 2023 年占据最大的市场份额。

细胞治疗仪器市场的地理分析

细胞治疗仪器市场报告的地理范围分为五个区域：北美、亚太、欧洲、中东和非洲以及南美/南美和中美洲。

美国是细胞治疗仪器的最大且成长最快的市场，这主要得益于研发投入的增加以及包括基因疗法、干细胞疗法和免疫疗法在内的细胞疗法的日益普及。此外，政府的支持也大大促进了细胞疗法的发展，对市场扩张产生了正面影响。例如，美国基因与细胞治疗学会（ASGCT）是一个公共组织，为从事基因和细胞治疗的科学家、医生、专业人士和患者权益倡导者提供会员资格，旨在提高人们对这些疗法临床应用的认识、教育和了解。

细胞治疗仪器市场报告范围

细胞治疗仪器市场的最新发展

细胞治疗仪器市场的评估是基于透过一手和二手研究收集的定性和定量资料，包括重要的企业出版物、协会资料和资料库。该市场近期发展动态包括：

  • 赛默飞世尔科技公司与机器人公司 Multiply Labs 达成协议，将加强双方在细胞疗法生产自动化方面的合作。 （资料来源：赛默飞世尔科技公司，2024 年）
  • MaxCyte公司推出了ExPERT系列仪器，旨在为下一代细胞疗法提供从概念到商业化的综合技术平台。 （资料来源：MaxCyte公司，新闻稿，2024年）

细胞治疗仪器市场报告覆盖范围及成果

题为《细胞治疗仪器市场规模及预测（2021-2031）》的报告对市场进行了深入分析，涵盖以下领域：

  • 涵盖范围内所有主要细分市场的全球、区域和国家层面的市场规模和预测。
  • 市场动态，包括驱动因素、限制因素和主要机会。
  • 未来主要趋势。
  • 全面的PEST/波特五力模型和SWOT分析。
  • 全球及区域市场分析，重点在于关键趋势、主要参与者、法规及最新发展。
  • 产业格局和竞争分析，包括市场集中度、热力图分析、主要参与者和最新发展。
  • 公司详细简介。

目录

第一章：引言

第二章：细胞治疗仪器市场及主要结论

第三章：研究方法

  • 覆盖范围
  • 二手研究
  • 初步研究

第四章：全球细胞治疗仪器及市场概况

  • 概述
  • PEST分析
    • 北美和PEST分析
    • 欧洲和PEST分析
    • 亚太地区及PEST分析
    • 中东和非洲 (MEA) 及 PEST 分析
    • 南美洲和中美洲（SCAM）及PEST分析
  • 专家意见

第五章：细胞治疗仪器市场及主要市场动态

  • 市场驱动因素
    • 细胞治疗製造技术的不断进步
    • 细胞疗法获准数量不断增加
  • 市场限制
    • 细胞疗法生产和细胞疗法的高成本
  • 市场机会
    • 发展中地区的成长机会
  • 未来趋势
    • 向自动化製造转型
  • 影响分析

第六章：细胞治疗仪器市场及全球分析

  • 全球细胞治疗仪器标记物收入预测与分析
  • 全球细胞治疗仪器市场（依地理划分）－预测与分析
  • 关键参与者的市场定位

第七章：细胞治疗仪器市场分析及产品分类

  • 概述
  • 细胞治疗仪器市场收入份额（按产品划分）（2024 年和 2031 年）
  • 消耗品
  • 装置
  • 系统和软体

第八章：细胞治疗仪器市场分析及细胞类型分类

  • 概述
  • 细胞治疗仪器市场收入份额（按细胞类型划分）（2024 年和 2031 年）
  • 人类细胞
  • 动物细胞

第九章：细胞治疗仪器市场分析及製程分类

  • 概述
  • 细胞治疗仪器市场收入份额（按製程划分）（2024 年和 2031 年）
  • 细胞处理
  • 过程监控和品质控制
  • 细胞保存、分发和处理

第十章：细胞治疗仪器市场分析及最终用户细分

  • 概述
  • 细胞治疗仪器市场份额（按最终用户划分），2024 年和 2031 年（%）
  • 研究机构
  • 生命科学研究公司
  • 其他最终用户

第十一章：细胞治疗仪器市场分析及至2031年预测及地理分析

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
  • 中东和非洲
    • 阿联酋
    • 沙乌地阿拉伯
    • 南非
  • 南美洲和中美洲
    • 巴西
    • 阿根廷

第十二章：新冠肺炎疫情对全球细胞治疗仪器市场的影响

  • 北美洲
  • 欧洲
  • 亚太
  • 世界其他地区

第十三章：行业概况

  • 概述
  • 市场中各公司采取的成长策略（%）
  • 有机发展
    • 概述
  • 无机物发展
    • 概述

第十四章：公司简介

  • THERMO FISHER SCIENTIFIC INC.
  • MERCK KGaA
  • Lonza
  • General Electric Company
  • Terumo Corporation
  • BD
  • Miltenyi Biotec
  • STEMCELL Technologies Inc.
  • Sartorius AG
  • Danaher (Beckman Coulter, Inc.)

第十五章：附录

简介目录
Product Code: TIPRE00003481

The market for cell therapy instruments was valued at approximately US$ 23.28 billion in 2024 and is projected to grow to around US$ 59.98 billion by 2031. This market is anticipated to experience a compound annual growth rate (CAGR) of 15.4% from 2031 to 2031, with a significant trend towards automated manufacturing in cell therapy instruments.

Analysis of the Cell Therapy Instrument Market

Cell therapy involves the injection, implantation, or grafting of living cells into a patient's body. For example, during immunotherapy, a cancer patient may receive T cell injections. The delivery methods for cell therapy instruments vary from simple injections to complex surgical implantations using specialized devices. Cell therapy is applicable to a wide range of conditions, with cancer being one of the most critical diseases affecting the nervous system. Other applications include cardiac issues (such as myocardial infarction and heart failure), diabetes, musculoskeletal disorders, genetic diseases, and skin and soft tissue wounds.

Overview of the Cell Therapy Instrument Market

Chimeric antigen receptor (CAR) T-cell therapy is one of the most promising cancer treatment methods, with numerous pre-clinical and clinical trials conducted annually to broaden its applications. After years of research, CAR-T cell therapy is set to expand further. Future developments will explore not only autologous and allogeneic products but also new in-vivo CAR-T cell gene therapies and their effectiveness in conditions beyond hematologic malignancies.

Strategic Insights

Drivers and Opportunities in the Cell Therapy Instrument Market

Advancements in Cell Therapy Manufacturing

Growing research in cell therapy has led to remarkable advancements in cell therapy instruments aimed at treating genetic disorders and enhancing immune responses. Various companies provide essential consumables like reagent kits and enzymes, while others offer the necessary instruments, equipment, and software for a wide array of cell therapy processes.

The use of specialized equipment is crucial for producing cell therapies such as T cells, hematopoietic stem cells (HSC), mesenchymal stem cells (MSC), pluripotent stem cells (PSC), and neural stem cells (NSC). Since these products are derived from human or animal cells, maintaining contamination-free conditions is vital. Consequently, the instruments used in cell therapies are designed to prevent contamination and facilitate increased production. Notable companies like Corning Incorporated, Hitachi Chemical Advanced Therapeutics Solutions, LLC, Cytiva (a General Electric Company), Thermo Fisher Scientific Inc., Invetech, and Miltenyi Biotec have developed various instruments and consumables for cell therapy applications.

The biotechnology industry in the Asia Pacific and Middle East regions is rapidly expanding, bolstered by significant investments and strategic initiatives from both private and public sectors, particularly in comparison to North America and Europe. For example, in December 2024, Astellas Pharma Inc. from Japan announced its acquisition of Audentes Therapeutics Inc., a gene therapy firm, for US$ 3 billion. Similarly, in November 2024, Fujifilm revealed plans to invest approximately US$ 120 million (13 billion yen) in gene therapy as part of its contract development and manufacturing segment. Additionally, the Japan Pharmaceutical Medical Device Agency (PMDA) approved two gene therapy products under the Sakigake designation, which is akin to the FDA's breakthrough therapy designation and the EMA's Priority Medicine (PRIME) designation, with expectations to approve at least one therapy annually. Such strategic moves by domestic players in Asian countries are likely to drive demand for cell therapy instruments in the near future.

Segmentation Analysis of the Cell Therapy Instrument Market

The analysis of the cell therapy instrument market is segmented by disorder and service providers.

  • The market is categorized by products into consumables, equipment, systems, and software, with the consumables segment holding the largest market share in 2023.
  • By cell type, the market is divided into human cells and animal cells, with thermoplastics representing the largest market share in 2023.
  • By process, the market is segmented into cell processing, process monitoring and quality control, cell preservation, distribution, and handling, with the cell processing segment leading in market share in 2023.
  • By end users, the market is categorized into research institutes, life science research companies, and other end users, with life science research companies holding the largest market share in 2023.

Geographical Analysis of the Cell Therapy Instrument Market

The geographical scope of the cell therapy instrument market report is divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South America/South & Central America.

The United States stands out as the largest and fastest-growing market for cell therapy instruments, driven by increased research and development and the rising adoption of cell therapies, including gene, stem cell, and immune therapies. Furthermore, government support is significantly contributing to the growth of cell therapies, positively impacting market expansion. For instance, the American Society of Gene & Cell Therapy (ASGCT) is a public organization that offers memberships to scientists, physicians, professionals, and patient advocates involved in gene and cell therapies, aiming to enhance knowledge, education, and awareness regarding the clinical applications of these therapies.

Scope of the Cell Therapy Instrument Market Report

Recent Developments in the Cell Therapy Instrument Market

The evaluation of the cell therapy instrument market is based on qualitative and quantitative data collected through primary and secondary research, including significant corporate publications, association data, and databases. Recent developments in the market include:

  • Thermo Fisher Scientific and robotics company Multiply Labs have entered into an agreement to enhance their collaboration in automating cell therapy production. (Source: Thermo Fisher Scientific, 2024).
  • MaxCyte has launched the ExPERT instrument family to provide a comprehensive technological platform for next-generation cellular therapies from concept to commercialization. (Source: MaxCyte, Press Release, 2024).

Report Coverage and Deliverables for the Cell Therapy Instrument Market

The report titled "Cell Therapy Instrument Market Size and Forecast (2021-2031)" offers an in-depth analysis of the market, covering the following areas:

  • Market size and forecast at global, regional, and country levels for all key market segments included in the scope.
  • Market dynamics, including drivers, restraints, and key opportunities.
  • Key future trends.
  • Comprehensive PEST/Porter's Five Forces and SWOT analysis.
  • Global and regional market analysis highlighting key trends, major players, regulations, and recent developments.
  • Industry landscape and competition analysis, including market concentration, heat map analysis, prominent players, and recent developments.
  • Detailed company profiles.

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Cell Therapy Instruments Market and By Product
    • 1.3.2 Cell Therapy Instruments Market and By Cell Type
    • 1.3.3 Cell Therapy Instruments Market and By Process
    • 1.3.4 Cell Therapy Instruments Market and By End User
    • 1.3.5 Global Cell Therapy Instruments Market and By Geography

2. Cell Therapy Instruments Market and Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Global Cell Therapy Instrumentsand Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 North America and PEST Analysis
    • 4.2.2 Europe and PEST Analysis
    • 4.2.3 Asia Pacific and PEST Analysis
    • 4.2.4 Middle East and Africa (MEA) and PEST Analysis
    • 4.2.5 South and Central America (SCAM) and PEST Analysis
  • 4.3 Expert Opinions

5. Cell Therapy Instruments Market and Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Increasing Developments in Cell Therapy Manufacturing
    • 5.1.2 Rising Number of Approvals for Cell-based Therapies
  • 5.2 Market Restraints
    • 5.2.1 High Cost Of Cell Therapy Production and Cell Therapy
  • 5.3 Market Opportunities
    • 5.3.1 Growth Opportunities in Developing Regions
  • 5.4 Future Trends
    • 5.4.1 Shift Toward Automated Manufacturing
  • 5.5 Impact Analysis

6. Cell Therapy Instruments Market and Global Analysis

  • 6.1 Global Cell Therapy Instrument Marker Revenue Forecast And Analysis
  • 6.2 Global Cell Therapy Instruments Market, By Geography - Forecast And Analysis
  • 6.3 Market Positioning of Key Players

7. Cell Therapy Instruments Market Analysis and By Product

  • 7.1 Overview
  • 7.2 Cell Therapy Instruments Market Revenue Share, by Product (2024 and 2031)
  • 7.3 Consumables
    • 7.3.1 Overview
    • 7.3.2 Consumables: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (US$ Million)
  • 7.4 Equipment
    • 7.4.1 Overview
    • 7.4.2 Equipment: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (US$ Million)
    • 7.4.3 Singleanduse Equipment
      • 7.4.3.1 Overview
      • 7.4.3.2 Singleanduse Equipment: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (US$ Million)
    • 7.4.4 Cell Processing Equipment
      • 7.4.4.1 Overview
      • 7.4.4.2 Cell Processing Equipment: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (US$ Million)
    • 7.4.5 Other Equipment
      • 7.4.5.1 Overview
      • 7.4.5.2 Other Equipment: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (US$ Million)
  • 7.5 Systems and Software
    • 7.5.1 Overview
    • 7.5.2 Systems and Software Segment: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (US$ Million)

8. Cell Therapy Instruments Market Analysis and By Cell Type

  • 8.1 Overview
  • 8.2 Cell Therapy Instruments Market Revenue Share, by Cell Type (2024 and 2031)
  • 8.3 Human Cells
    • 8.3.1 Human Cells: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (US$ Million)
    • 8.3.2 Differentiated Cells
      • 8.3.2.1 Overview
      • 8.3.2.2 Differentiated Cells: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (US$ Million)
    • 8.3.3 Stem Cells
      • 8.3.3.1 Overview
      • 8.3.3.2 Stem Cells: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (US$ Million)
  • 8.4 Animal Cells
    • 8.4.1 Overview
    • 8.4.2 Animal Cells : Cell Therapy Instruments Market and Revenue and Forecast to 2031 (US$ Million)

9. Cell Therapy Instruments Market Analysis and By Process

  • 9.1 Overview
  • 9.2 Cell Therapy Instruments Market Revenue Share, by Process (2024 and 2031)
  • 9.3 Cell Processing
    • 9.3.1 Cell Processing: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (US$ Million)
  • 9.4 Process Monitoring and Quality Control
    • 9.4.1 Process Monitoring and Quality Control: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (US$ Million)
  • 9.5 Cell Preservation, Distribution, and Handling
    • 9.5.1 Cell Preservation, Distribution, and Handling: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (US$ Million)

10. Cell Therapy Instruments Market Analysis and By End User

  • 10.1 Overview
  • 10.2 Cell Therapy Instruments Market Share, by End Users, 2024 and 2031, (%)
  • 10.3 Research Institutes
    • 10.3.1 Overview
    • 10.3.2 Research Institutes: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (US$ Million)
  • 10.4 Life Science Research Companies
    • 10.4.1 Overview
    • 10.4.2 Life Science Research Companies : Cell therapy instruments market and Revenue and Forecast to 2031 (US$ Million)
  • 10.5 Other End Users
    • 10.5.1 Overview
    • 10.5.2 Other End Users: Cell therapy instruments market and Revenue and Forecast to 2031 (US$ Million)

11. Cell Therapy Instruments Market Analysis And Forecast to 2031 and Geographical Analysis

  • 11.1 North America: Cell Therapy Instruments Market
    • 11.1.1 Overview
    • 11.1.2 North America: Cell Therapy Instruments Market,- Revenue and Forecast to 2031 (USD Million)
    • 11.1.3 North America: Cell Therapy Instruments Market, by Product and Revenue and Forecast to 2031 (USD Million)
      • 11.1.3.1 North America: Equipment Market, by Type and Revenue and Forecast to 2031 (USD Million)
    • 11.1.4 North America: Cell Therapy Instruments Market, by Cell Type and Revenue and Forecast to 2031 (USD Million)
      • 11.1.4.1 North America: Human Cells Market, by Type and Revenue and Forecast to 2031 (USD Million)
    • 11.1.5 North America: Cell Therapy Instruments Market, by Process and Revenue and Forecast to 2031 (USD Million)
    • 11.1.6 North America: Cell Therapy Instruments Market, by End User and Revenue and Forecast to 2031 (USD Million)
    • 11.1.7 North America: Cell Therapy Instruments Market, by Country, 2024 and 2031 (%)
    • 11.1.8 US: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (USD Million)
      • 11.1.8.1 US: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (USD Million)
      • 11.1.8.2 US: Cell Therapy Instruments Market, by Product and Revenue and Forecast to 2031 (USD Million)
        • 11.1.8.2.1 US: Equipment Market,, by Type and Revenue and Forecast to 2031 (USD Million)
      • 11.1.8.3 US: Cell Therapy Instruments Market, by Cell Type and Revenue and Forecast to 2031 (USD Million)
        • 11.1.8.3.1 US: Human Cells Market, by Type and Revenue and Forecast to 2031 (USD Million)
      • 11.1.8.4 US: Cell Therapy Instruments Market, by Process and Revenue and Forecast to 2031 (USD Million)
      • 11.1.8.5 US: Cell Therapy Instruments Market, by End User and Revenue and Forecast to 2031 (USD Million)
    • 11.1.9 Canada: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (USD Million)
      • 11.1.9.1 Canada: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (USD Million)
      • 11.1.9.2 Canada: Cell Therapy Instruments Market, by Product and Revenue and Forecast to 2031 (USD Million)
        • 11.1.9.2.1 Canada: Equipment Market,, by Type and Revenue and Forecast to 2031 (USD Million)
      • 11.1.9.3 Canada: Cell Therapy Instruments Market, by Cell Type and Revenue and Forecast to 2031 (USD Million)
        • 11.1.9.3.1 Canada: Human Cells Market,, by Type and Revenue and Forecast to 2031 (USD Million)
      • 11.1.9.4 Canada: Cell Therapy Instruments Market, by Process and Revenue and Forecast to 2031 (USD Million)
      • 11.1.9.5 Canada: Cell Therapy Instruments Market, by End User and Revenue and Forecast to 2031 (USD Million)
    • 11.1.10 Mexico: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (USD Million)
      • 11.1.10.1 Mexico: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (USD Million)
      • 11.1.10.2 Mexico: Cell Therapy Instruments Market, by Product and Revenue and Forecast to 2031 (USD Million)
        • 11.1.10.2.1 Mexico: Equipment Market,, by Type and Revenue and Forecast to 2031 (USD Million)
      • 11.1.10.3 Mexico: Cell Therapy Instruments Market, by Cell Type and Revenue and Forecast to 2031 (USD Million)
        • 11.1.10.3.1 Mexico: Human Cells Market,, by Type and Revenue and Forecast to 2031 (USD Million)
      • 11.1.10.4 Mexico: Cell Therapy Instruments Market, by Process and Revenue and Forecast to 2031 (USD Million)
      • 11.1.10.5 Mexico: Cell Therapy Instruments Market, by End User and Revenue and Forecast to 2031 (USD Million)
  • 11.2 Europe: Cell Therapy Instruments Market
    • 11.2.1 Overview
    • 11.2.2 Europe: Cell Therapy Instruments Market - Revenue and Forecast to 2031 (USD Million)
    • 11.2.3 Europe: Cell Therapy Instruments Market, by Product, 2024 and 2031 (USD Millions)
      • 11.2.3.1 Europe: Equipment Market, by Type, 2024 and 2031 (USD Millions)
    • 11.2.4 Europe: Cell Therapy Instruments Market, by Cell Type, 2024 and 2031 (USD Million)
      • 11.2.4.1 Europe: Human Cells Market, by Type, 2024 and 2031 (USD Million)
    • 11.2.5 Europe: Cell Therapy Instruments Market, by Process, 2024 and 2031 (USD Million)
    • 11.2.6 Europe: Cell Therapy Instruments Market, by End User, 2024 and 2031 (USD Million)
    • 11.2.7 Europe: Cell Therapy Instruments Market, by Country, 2019 and 2031 (%)
    • 11.2.8 Germany: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (USD Million)
      • 11.2.8.1 Germany: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (USD Million)
      • 11.2.8.2 Germany: Cell Therapy Instruments Market, by Product, 2024 and 2031 (USD Millions)
        • 11.2.8.2.1 Germany: Equipment Market, by Type, 2024 and 2031 (USD Millions)
      • 11.2.8.3 Germany: Cell Therapy Instruments Market, by Cell Type, 2024 and 2031 (USD Million)
        • 11.2.8.3.1 Germany: Human Cells Market, by Type, 2024 and 2031 (USD Million)
      • 11.2.8.4 Germany: Cell Therapy Instruments Market, by Process, 2024 and 2031 (USD Million)
      • 11.2.8.5 Germany: Cell Therapy Instruments Market, by End User, 2024 and 2031 (USD Million)
    • 11.2.9 France: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (USD Million)
      • 11.2.9.1 France: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (USD Million)
      • 11.2.9.2 France: Cell Therapy Instruments Market, by Product, 2024 and 2031 (USD Millions)
        • 11.2.9.2.1 France: Equipment Market, by Type, 2024 and 2031 (USD Millions)
      • 11.2.9.3 France: Cell Therapy Instruments Market, by Cell Type, 2024 and 2031 (USD Million)
        • 11.2.9.3.1 France: Human Cells Market, by Type, 2024 and 2031 (USD Million)
      • 11.2.9.4 France: Cell Therapy Instruments Market, by Process, 2024 and 2031 (USD Million)
      • 11.2.9.5 France: Cell Therapy Instruments Market, by End User, 2024 and 2031 (USD Million)
    • 11.2.10 UK: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (USD Million)
      • 11.2.10.1 UK: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (USD Million)
      • 11.2.10.2 UK: Cell Therapy Instruments Market, by Product, 2024 and 2031 (USD Millions)
        • 11.2.10.2.1 UK: Equipment Market, by Type, 2024 and 2031 (USD Millions)
      • 11.2.10.3 UK: Cell Therapy Instruments Market, by Cell Type, 2024 and 2031 (USD Million)
        • 11.2.10.3.1 UK: Human Cells Market, by Type, 2024 and 2031 (USD Million)
      • 11.2.10.4 UK: Cell Therapy Instruments Market, by Process, 2024 and 2031 (USD Million)
      • 11.2.10.5 UK: Cell Therapy Instruments Market, by End User, 2024 and 2031 (USD Million)
    • 11.2.11 Italy: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (USD Million)
      • 11.2.11.1 Italy: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (USD Million)
      • 11.2.11.2 Italy: Cell Therapy Instruments Market, by Product, 2024 and 2031 (USD Millions)
        • 11.2.11.2.1 Italy: Equipment Market, by Type, 2024 and 2031 (USD Millions)
      • 11.2.11.3 Italy: Cell Therapy Instruments Market, by Cell Type, 2024 and 2031 (USD Million)
        • 11.2.11.3.1 Italy: Human Cells Market, by Type, 2024 and 2031 (USD Million)
      • 11.2.11.4 Italy: Cell Therapy Instruments Market, by Process, 2024 and 2031 (USD Million)
      • 11.2.11.5 Italy: Cell Therapy Instruments Market, by End User, 2024 and 2031 (USD Million)
    • 11.2.12 Spain: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (USD Million)
      • 11.2.12.1 Spain: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (USD Million)
      • 11.2.12.2 Spain: Cell Therapy Instruments Market, by Product, 2024 and 2031 (USD Millions)
        • 11.2.12.2.1 Spain: Equipment Market, by Type, 2024 and 2031 (USD Millions)
      • 11.2.12.3 Spain: Cell Therapy Instruments Market, by Cell Type, 2024 and 2031 (USD Million)
        • 11.2.12.3.1 Spain: Human Cells Market, by Type, 2024 and 2031 (USD Million)
      • 11.2.12.4 Spain: Cell Therapy Instruments Market, by Process, 2024 and 2031 (USD Million)
      • 11.2.12.5 Spain: Cell Therapy Instruments Market, by End User, 2024 and 2031 (USD Million)
  • 11.3 Asia Pacific: Cell Therapy Instruments Market
    • 11.3.1 Overview
    • 11.3.2 Asia Pacific: Cell Therapy Instruments Market - Revenue and Forecast to 2031 (USD Million)
    • 11.3.3 Asia Pacific: Cell Therapy Instruments Market, by Product, 2024 and 2031 (USD Millions)
      • 11.3.3.1 Asia Pacific: Equipment Market, by Type, 2024 and 2031 (USD Millions)
    • 11.3.4 Asia Pacific: Cell Therapy Instruments Market, by Cell Type, 2024 and 2031 (USD Million)
      • 11.3.4.1 Asia Pacific: Human Cells Market, by Type, 2024 and 2031 (USD Million)
    • 11.3.5 Asia Pacific: Cell Therapy Instruments Market, by Process, 2024 and 2031 (USD Million)
    • 11.3.6 Asia Pacific: Cell Therapy Instruments Market, by End User, 2024 and 2031 (USD Million)
    • 11.3.7 Asia Pacific: Cell Therapy Instruments Market, by Country, 2019 and 2031 (%)
    • 11.3.8 China: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (USD Million)
      • 11.3.8.1 China: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (USD Million)
      • 11.3.8.2 China: Cell Therapy Instruments Market, by Product, 2024 and 2031 (USD Millions)
        • 11.3.8.2.1 China: Equipment Market, by Type, 2024 and 2031 (USD Millions)
      • 11.3.8.3 China: Cell Therapy Instruments Market, by Cell Type, 2024 and 2031 (USD Million)
        • 11.3.8.3.1 China: Human Cells Market, by Type, 2024 and 2031 (USD Million)
      • 11.3.8.4 China: Cell Therapy Instruments Market, by Process, 2024 and 2031 (USD Million)
      • 11.3.8.5 China: Cell Therapy Instruments Market, by End User, 2024 and 2031 (USD Million)
    • 11.3.9 Japan: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (USD Million)
      • 11.3.9.1 Japan: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (USD Million)
      • 11.3.9.2 Japan: Cell Therapy Instruments Market, by Product, 2024 and 2031 (USD Millions)
        • 11.3.9.2.1 Japan: Equipment Market, by Type, 2024 and 2031 (USD Millions)
      • 11.3.9.3 Japan: Cell Therapy Instruments Market, by Cell Type, 2024 and 2031 (USD Million)
        • 11.3.9.3.1 Japan: Human Cells Market, by Type, 2024 and 2031 (USD Million)
      • 11.3.9.4 Japan: Cell Therapy Instruments Market, by Process, 2024 and 2031 (USD Million)
      • 11.3.9.5 Japan: Cell Therapy Instruments Market, by End User, 2024 and 2031 (USD Million)
    • 11.3.10 India: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (USD Million)
      • 11.3.10.1 India: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (USD Million)
      • 11.3.10.2 India: Cell Therapy Instruments Market, by Product, 2024 and 2031 (USD Millions)
        • 11.3.10.2.1 India: Equipment Market, by Type, 2024 and 2031 (USD Millions)
      • 11.3.10.3 India: Cell Therapy Instruments Market, by Cell Type, 2024 and 2031 (USD Million)
        • 11.3.10.3.1 India: Human Cells Market, by Type, 2024 and 2031 (USD Million)
      • 11.3.10.4 India: Cell Therapy Instruments Market, by Process, 2024 and 2031 (USD Million)
      • 11.3.10.5 India: Cell Therapy Instruments Market, by End User, 2024 and 2031 (USD Million)
    • 11.3.11 South Korea: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (USD Million)
      • 11.3.11.1 South Korea: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (USD Million)
      • 11.3.11.2 South Korea : Cell Therapy Instruments Market, by Product, 2024 and 2031 (USD Millions)
        • 11.3.11.2.1 South Korea : Equipment Market, by Type, 2024 and 2031 (USD Millions)
      • 11.3.11.3 South Korea : Cell Therapy Instruments Market, by Cell Type, 2024 and 2031 (USD Million)
        • 11.3.11.3.1 South Korea : Human Cells Market, by Type, 2024 and 2031 (USD Million)
      • 11.3.11.4 South Korea : Cell Therapy Instruments Market, by Process, 2024 and 2031 (USD Million)
      • 11.3.11.5 South Korea : Cell Therapy Instruments Market, by End User, 2024 and 2031 (USD Million)
    • 11.3.12 Australia: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (USD Million)
      • 11.3.12.1 Australia: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (USD Million)
      • 11.3.12.2 Australia: Cell Therapy Instruments Market, by Product, 2024 and 2031 (USD Millions)
        • 11.3.12.2.1 Australia: Equipment Market, by Type, 2024 and 2031 (USD Millions)
      • 11.3.12.3 Australia: Cell Therapy Instruments Market, by Cell Type, 2024 and 2031 (USD Million)
        • 11.3.12.3.1 Australia: Human Cells Market, by Type, 2024 and 2031 (USD Million)
      • 11.3.12.4 Australia: Cell Therapy Instruments Market, by Process, 2024 and 2031 (USD Million)
      • 11.3.12.5 Australia: Cell Therapy Instruments Market, by End User, 2024 and 2031 (USD Million)
  • 11.4 Middle East and Africa: Cell Therapy Instruments Market
    • 11.4.1 Overview
    • 11.4.2 Middle East and Africa: Cell Therapy Instruments Market - Revenue and Forecast to 2031 (USD Million)
    • 11.4.3 Middle East and Africa: Cell Therapy Instruments Market, by Product, 2024 and 2031 (USD Millions)
      • 11.4.3.1 Middle East and Africa: Equipment Market, by Type, 2024 and 2031 (USD Millions)
    • 11.4.4 Middle East and Africa: Cell Therapy Instruments Market, by Cell Type, 2024 and 2031 (USD Million)
      • 11.4.4.1 Middle East and Africa: Human Cells Market, by Type, 2024 and 2031 (USD Million)
    • 11.4.5 Middle East and Africa: Cell Therapy Instruments Market, by Process, 2024 and 2031 (USD Million)
    • 11.4.6 Middle East and Africa: Cell Therapy Instruments Market, by End User, 2024 and 2031 (USD Million)
    • 11.4.7 Middle East and Africa: Cell Therapy Instruments Market, by Country, 2019 and 2031 (%)
    • 11.4.8 UAE: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (USD Million)
      • 11.4.8.1 UAE: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (USD Million)
      • 11.4.8.2 UAE: Cell Therapy Instruments Market, by Product, 2024 and 2031 (USD Millions)
        • 11.4.8.2.1 UAE: Equipment Market, by Type, 2024 and 2031 (USD Millions)
      • 11.4.8.3 UAE: Cell Therapy Instruments Market, by Cell Type, 2024 and 2031 (USD Million)
        • 11.4.8.3.1 UAE: Human Cells Market, by Type, 2024 and 2031 (USD Million)
      • 11.4.8.4 UAE: Cell Therapy Instruments Market, by Process, 2024 and 2031 (USD Million)
      • 11.4.8.5 UAE: Cell Therapy Instruments Market, by End User, 2024 and 2031 (USD Million)
    • 11.4.9 Saudi Arabia: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (USD Million)
      • 11.4.9.1 Saudi Arabia: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (USD Million)
      • 11.4.9.2 Saudi Arabia: Cell Therapy Instruments Market, by Product, 2024 and 2031 (USD Millions)
        • 11.4.9.2.1 Saudi Arabia: Equipment Market, by Type, 2024 and 2031 (USD Millions)
      • 11.4.9.3 Saudi Arabia: Cell Therapy Instruments Market, by Cell Type, 2024 and 2031 (USD Million)
        • 11.4.9.3.1 Saudi Arabia: Human Cells Market, by Type, 2024 and 2031 (USD Million)
      • 11.4.9.4 Saudi Arabia: Cell Therapy Instruments Market, by Process, 2024 and 2031 (USD Million)
      • 11.4.9.5 Saudi Arabia: Cell Therapy Instruments Market, by End User, 2024 and 2031 (USD Million)
    • 11.4.10 South Africa: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (USD Million)
      • 11.4.10.1 South Africa: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (USD Million)
      • 11.4.10.2 South Africa: Cell Therapy Instruments Market, by Product, 2024 and 2031 (USD Millions)
        • 11.4.10.2.1 South Africa: Equipment Market, by Type, 2024 and 2031 (USD Millions)
      • 11.4.10.3 South Africa: Cell Therapy Instruments Market, by Cell Type, 2024 and 2031 (USD Million)
        • 11.4.10.3.1 South Africa: Human Cells Market, by Type, 2024 and 2031 (USD Million)
      • 11.4.10.4 South Africa: Cell Therapy Instruments Market, by Process, 2024 and 2031 (USD Million)
      • 11.4.10.5 South Africa: Cell Therapy Instruments Market, by End User, 2024 and 2031 (USD Million)
  • 11.5 South and Central America: Cell Therapy Instruments Market
    • 11.5.1 Overview
    • 11.5.2 South and Central America: Cell Therapy Instruments Market - Revenue and Forecast to 2031 (US$ Million)
    • 11.5.3 South and Central America: Cell Therapy Instruments Market, by Product, 2024 and 2031 (USD Millions)
      • 11.5.3.1 South and Central America: Equipment Market, by Type, 2024 and 2031 (USD Millions)
    • 11.5.4 South and Central America: Cell Therapy Instruments Market, by Cell Type, 2024 and 2031 (USD Million)
      • 11.5.4.1 South and Central America: Human Cells Market, by Type, 2024 and 2031 (USD Million)
    • 11.5.5 South and Central America: Cell Therapy Instruments Market, by Process, 2024 and 2031 (USD Million)
    • 11.5.6 South and Central America: Cell Therapy Instruments Market, by End User, 2024 and 2031 (USD Million)
    • 11.5.7 South and Central America: Cell Therapy Instruments Market, by Country, 2019 and 2031 (%)
    • 11.5.8 Brazil: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (USD Million)
      • 11.5.8.1 Brazil: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (USD Million)
      • 11.5.8.2 Brazil: Cell Therapy Instruments Market, by Product, 2024 and 2031 (USD Millions)
        • 11.5.8.2.1 Brazil: Equipment Market, by Type, 2024 and 2031 (USD Millions)
      • 11.5.8.3 Brazil: Cell Therapy Instruments Market, by Cell Type, 2024 and 2031 (USD Million)
        • 11.5.8.3.1 Brazil: Human Cells Market, by Type, 2024 and 2031 (USD Million)
      • 11.5.8.4 Brazil: Cell Therapy Instruments Market, by Process, 2024 and 2031 (USD Million)
      • 11.5.8.5 Brazil: Cell Therapy Instruments Market, by End User, 2024 and 2031 (USD Million)
    • 11.5.9 Argentina: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (USD Million)
      • 11.5.9.1 Argentina: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (USD Million)
      • 11.5.9.2 Argentina: Cell Therapy Instruments Market, by Product, 2024 and 2031 (USD Millions)
        • 11.5.9.2.1 Argentina: Equipment Market, by Type, 2024 and 2031 (USD Millions)
      • 11.5.9.3 Argentina: Cell Therapy Instruments Market, by Cell Type, 2024 and 2031 (USD Million)
        • 11.5.9.3.1 Argentina: Human Cells Market, by Type, 2024 and 2031 (USD Million)
      • 11.5.9.4 Argentina: Cell Therapy Instruments Market, by Process, 2024 and 2031 (USD Million)
      • 11.5.9.5 Argentina: Cell Therapy Instruments Market, by End User, 2024 and 2031 (USD Million)

12. Impact of COVID-19 Pandemic on Global Cell Therapy Instruments Market

  • 12.1 North America: Impact Assessment of COVID-19 Pandemic
  • 12.2 Europe: Impact Assessment of COVID-19 Pandemic
  • 12.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
  • 12.4 Rest of the World: Impact Assessment of COVID-19 Pandemic

13. Industry Landscape

  • 13.1 Overview
  • 13.2 Growth Strategies Done by the Companies in the Market, (%)
  • 13.3 Organic Developments
    • 13.3.1 Overview
  • 13.4 Inorganic Developments
    • 13.4.1 Overview

14. Company Profiles

  • 14.1 THERMO FISHER SCIENTIFIC INC.
    • 14.1.1 Key Facts
    • 14.1.2 Business Description
    • 14.1.3 Products and Services
    • 14.1.4 Financial Overview
    • 14.1.5 SWOT Analysis
    • 14.1.6 Key Developments
  • 14.2 MERCK KGaA
    • 14.2.1 Key Facts
    • 14.2.2 Business Description
    • 14.2.3 Products and Services
    • 14.2.4 Financial Overview
    • 14.2.5 SWOT Analysis
    • 14.2.6 Key Developments
  • 14.3 Lonza
    • 14.3.1 Key Facts
    • 14.3.2 Business Description
    • 14.3.3 Products and Services
    • 14.3.4 Financial Overview
    • 14.3.5 SWOT Analysis
    • 14.3.6 Key Developments
  • 14.4 General Electric Company
    • 14.4.1 Key Facts
    • 14.4.2 Business Description
    • 14.4.3 Products and Services
    • 14.4.4 Financial Overview
    • 14.4.5 SWOT Analysis
    • 14.4.6 Key Developments
  • 14.5 Terumo Corporation
    • 14.5.1 Key Facts
    • 14.5.2 Business Description
    • 14.5.3 Products and Services
    • 14.5.4 Financial Overview
    • 14.5.5 SWOT Analysis
    • 14.5.6 Key Developments
  • 14.6 BD
    • 14.6.1 Key Facts
    • 14.6.2 Business Description
    • 14.6.3 Products and Services
    • 14.6.4 Financial Overview
    • 14.6.5 SWOT Analysis
    • 14.6.6 Key Developments
  • 14.7 Miltenyi Biotec
    • 14.7.1 Key Facts
    • 14.7.2 Business Description
    • 14.7.3 Products and Services
    • 14.7.4 Financial Overview
    • 14.7.5 SWOT Analysis
    • 14.7.6 Key Developments
  • 14.8 STEMCELL Technologies Inc.
    • 14.8.1 Key Facts
    • 14.8.2 Business Description
    • 14.8.3 Products and Services
    • 14.8.4 Financial Overview
    • 14.8.5 SWOT Analysis
    • 14.8.6 Key Developments
  • 14.9 Sartorius AG
    • 14.9.1 Key Facts
    • 14.9.2 Business Description
    • 14.9.3 Products and Services
    • 14.9.4 Financial Overview
    • 14.9.5 SWOT Analysis
    • 14.9.6 Key Developments
  • 14.10 Danaher (Beckman Coulter, Inc.)
    • 14.10.1 Key Facts
    • 14.10.2 Business Description
    • 14.10.3 Products and Services
    • 14.10.4 Financial Overview
    • 14.10.5 SWOT Analysis
    • 14.10.6 Key Developments

15. Appendix

  • 15.1 Glossary of Terms